These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Recent update on the heterogeneity of the Alzheimer's disease spectrum. Jellinger KA J Neural Transm (Vienna); 2022 Jan; 129(1):1-24. PubMed ID: 34919190 [TBL] [Abstract][Full Text] [Related]
24. Review: Neuropathology and behavioural features of transgenic murine models of Alzheimer's disease. Ameen-Ali KE; Wharton SB; Simpson JE; Heath PR; Sharp P; Berwick J Neuropathol Appl Neurobiol; 2017 Dec; 43(7):553-570. PubMed ID: 28880417 [TBL] [Abstract][Full Text] [Related]
25. Human Alzheimer's disease gene expression signatures and immune profile in APP mouse models: a discrete transcriptomic view of Aβ plaque pathology. Rothman SM; Tanis KQ; Gandhi P; Malkov V; Marcus J; Pearson M; Stevens R; Gilliland J; Ware C; Mahadomrongkul V; O'Loughlin E; Zeballos G; Smith R; Howell BJ; Klappenbach J; Kennedy M; Mirescu C J Neuroinflammation; 2018 Sep; 15(1):256. PubMed ID: 30189875 [TBL] [Abstract][Full Text] [Related]
26. The Alzheimer's plaques, tangles and memory deficits may have a common origin. Part V: why is Ca2+ signal lower in the disease? Chen M; Fernandez HL Front Biosci; 1999 Apr; 4():A9-15. PubMed ID: 10099137 [TBL] [Abstract][Full Text] [Related]
27. Insights into the Pathophysiology of Alzheimer's Disease and Potential Therapeutic Targets: A Current Perspective. Rajah Kumaran K; Yunusa S; Perimal E; Wahab H; Müller CP; Hassan Z J Alzheimers Dis; 2023; 91(2):507-530. PubMed ID: 36502321 [TBL] [Abstract][Full Text] [Related]
28. Increased mtDNA mutations with aging promotes amyloid accumulation and brain atrophy in the APP/Ld transgenic mouse model of Alzheimer's disease. Kukreja L; Kujoth GC; Prolla TA; Van Leuven F; Vassar R Mol Neurodegener; 2014 May; 9():16. PubMed ID: 24885175 [TBL] [Abstract][Full Text] [Related]
34. Liraglutide Protects Against Brain Amyloid-β Duarte AI; Candeias E; Alves IN; Mena D; Silva DF; Machado NJ; Campos EJ; Santos MS; Oliveira CR; Moreira PI Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143329 [TBL] [Abstract][Full Text] [Related]
35. Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease. Baazaoui N; Flory M; Iqbal K J Alzheimers Dis; 2017; 56(4):1385-1401. PubMed ID: 28222506 [TBL] [Abstract][Full Text] [Related]
36. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Koronyo-Hamaoui M; Koronyo Y; Ljubimov AV; Miller CA; Ko MK; Black KL; Schwartz M; Farkas DL Neuroimage; 2011 Jan; 54 Suppl 1():S204-17. PubMed ID: 20550967 [TBL] [Abstract][Full Text] [Related]
37. Human gut microbiota Agathobaculum butyriciproducens improves cognitive impairment in LPS-induced and APP/PS1 mouse models of Alzheimer's disease. Go J; Chang DH; Ryu YK; Park HY; Lee IB; Noh JR; Hwang DY; Kim BC; Kim KS; Lee CH Nutr Res; 2021 Feb; 86():96-108. PubMed ID: 33551257 [TBL] [Abstract][Full Text] [Related]